BrightPath Biotherapeutics Co., Ltd.

¥37.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4594Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (24.06%)
Div yield —
ROE (79.25%)
Biotechnology
Beta (5Y) 1.32
PE TTM —
TSR TTM (41.27%)
Mkt cap ¥5.139B
ROIC (48.78%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥46
24.01%
(95.73%)
Hold 5|8|1|6|7
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
0.57
0.56
0.54
0.55
14.49%
10.96%
1.27%
6.93%
Revenue¥M
415.7
428.9
434.7
433.4
(0.12%)
4.38%
1.23%
2.33%
Peers (US$32.63M)
Cap (US$)
PE
34.16M
76.75x
32.55M
24.18x
Capital
TTM
5Y
10Y
Leveragex
0.780
0.066
0.063
EBIT/Intx
3.858
0.258
0.258
Own earn%
0.38
(150.55)
(105.86)
Sh yield%
45.49
23.44
22.50
Owners
Insiders/Inst%
11.48
76.63
Short interest%
5.72
SBC / revenue%
3.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
3–8
$1 testx
—
Incr. ROIC%
4